Quantcast

Latest HPV vaccine Stories

2014-08-22 12:25:19

LA JOLLA, Cali., Aug. 22, 2014 /PRNewswire/ -- Research presented at the 29(th) Annual International Papillomavirus Conference shows that a therapy being developed by Hera Therapeutics Inc. combats three types of human papillomavirus, including the two that cause 70 percent of all cervical cancer. When tested in several cultured human cell models, HTI-1968 blocked the replication of HPV-16, HPV-18 and HPV-11 cells, according to Louise T. Chow, Ph.D. and Thomas Broker, Ph.D., who...

2014-08-21 23:15:41

Lesscancer.org Board member Margaret I. Cuomo, M. D. is a member of New York State Comprehensive Cancer Control Plan. (PRWEB) August 21, 2014 Next Generation Choices Foundation, more widely known as Lesscancer.org, is pleased to announce the launch of the New York State Comprehensive Cancer Control Plan Dashboard (the Dashboard) in partnership with the New York State Cancer Consortium (the Consortium). The Consortium is a network of individuals and organizations that collaborate to...

2014-08-01 10:49:36

Landes Bioscience A long-term follow-up study (HPV-023; NCT00518336) shows the sustained efficacy, immunogenicity and safety of GlaxoSmithKline's human papilloma virus (HPV) vaccine Cervarix. Women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine were followed for more than nine years, and vaccine efficacy (VE) against incident infection was 100%. This is the longest follow-up report for a licensed HPV vaccine. Visit https://www.landesbioscience.com/journals/vaccines/article/29532/...

2014-07-23 08:32:38

Treatment with VGX-3100 induces regression of precancerous cervical disease and clears HPV infection with robust T cell responses PLYMOUTH MEETING, Pa., July 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced successful results from its randomized, double-blind, placebo-controlled phase II trial of VGX-3100 in women with biopsy-proven cervical intraepithelial neoplasia 2/3 (CIN2/3) associated with human papillomavirus (HPV) types 16 or 18. Treatment...

2014-06-23 04:20:45

Inovio's Immunotherapy will Treat Women with Inoperable HPV-caused Cancer BLUE BELL, Pa., June 23, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase I/IIa clinical trial to evaluate safety, immunogenicity, clinical responses and disease-free survival of its DNA immunotherapy product, INO-3112, in treating human papillomavirus (HPV)-associated cervical cancer. INO-3112 is a combination of Inovio's lead active immunotherapy...

2014-06-17 23:02:39

New research report “Human Papillomavirus Infections Vaccine Pipeline Analysis” drawn up by PNS Pharma is available at MarketPublishers.com. London, UK (PRWEB) June 17, 2014 Human papillomaviruses represent a group of over 150 viruses which are related to each other, with certain types of viruses being able to cause warts (papillomas). There exist only two human papillomavirus vaccines which are currently marketed worldwide. Both these vaccines are prepared with the use of the...

2014-06-10 23:14:19

Christopher Shaw, PhD, a funded researcher by Children’s Medical Safety Research Institute (CMSRI), was mentioned in the Huffington Post for his stance regarding the cervical cancer vaccine. Fairfax, VA (PRWEB) June 10, 2014 Christopher Shaw, PhD, a scientific advisory board member of Children’s Medical Safety Research Institute (CMSRI), founded by Claire Dwoskin of the Dwoskin Family Foundation, was featured in Huffington Post, defending his stance regarding the cervical cancer...

2014-06-10 12:30:44

LONDON, June 10, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2014http://www.reportbuyer.com/pharma_healthcare/treatments/human_papillomavirus_hpv_associated_cancer_pipeline_review_h1_2013.html Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2014SummaryGlobal Markets Direct's, 'Human papillomavirus (HPV) Associated Cancer - Pipeline Review, H1 2014', provides an...

2014-06-01 23:02:52

A new survey found that “More than two-thirds of healthy Americans are teeming with HPV,” according to a report by NBC News published on May 20, 2014 (1). polyDNA reviews the report, and recommends Gene-Eden-VIR and Novirin to help the immune system target the latent human papillomavirus (HPV). Rochester, NY (PRWEB) June 01, 2014 A majority of Americans are infected with one or more strains of the human papillomavirus (HPV) (1). Dr. Yingfei Ma said that “The HPV 'community'...

2014-05-27 23:10:19

“Only 24% of (Hispanic male) participants believed that the HPV vaccine could prevent future problems, and 53% said they would not be vaccinate,” according to the Journal of Transcultural Nursing from May 19, 2014 (1). polyDNA reviews the study and recommends Gene-Eden-VIR and Novirin to help the immune systems target the latent human papillomavirus. Rochester, NY (PRWEB) May 27, 2014 A new study reported the attitudes of Hispanic men regarding HPV vaccination. Researchers learned...


Latest HPV vaccine Reference Libraries

0_d7e189bb6feb0f5663af7d072b6f51c6
2011-02-17 14:56:32

A human papillomavirus (HPV), a member of the papillomavirus family, is capable of infecting humans. HPVs establish productive infections in the skin or mucous membranes. Most of the 200 known types cause no symptoms in most people. Some types can cause warts, while others can lead to cancer. There are more than 30 to 40 types of HPV that are typically transmitted through sexual contact and infect the anogenital region. High risk HPV, can lead to cancer, in fact HPV infection is a cause of...

More Articles (1 articles) »
Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related